ITGA4 and B-cell chronic lymphocytic leukemia: This notwithstanding, in all three cohorts analyzed separately or merged together, CD49d+ CLL mostly failed to display an increase of the median ALC values at the analyzed time points, whereas the typical ibrutinib-induced early peak of ALC values was observed in CD49d− CLL (Fig. 4 B, bottom).